A case of mood disorder with severe side effects of antidepressants in association with resistance to thyroid hormone beta with a THRB mutation

Bibliographic Details
Title: A case of mood disorder with severe side effects of antidepressants in association with resistance to thyroid hormone beta with a THRB mutation
Authors: Hazuki Komahashi‐Sasaki, Norio Yasui‐Furukori, Ryo Maehara, Chie Hasegawa, Kazutaka Shimoda
Source: Neuropsychopharmacology Reports, Vol 42, Iss 3, Pp 391-394 (2022)
Publisher Information: Wiley, 2022.
Publication Year: 2022
Collection: LCC:Therapeutics. Pharmacology
LCC:Neurosciences. Biological psychiatry. Neuropsychiatry
Subject Terms: antidepressants, depression, Refetoff syndrome, RTHβ, side effects, Therapeutics. Pharmacology, RM1-950, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
More Details: Abstract Background Although resistance to thyroid hormone beta (RTHβ) is associated with attention‐deficit/hyperactivity disorder, there are few reports of other concomitant mood disorders in individuals with RTHβ. Case presentation A 67‐year‐old woman who had been previously diagnosed with RTHβ (Refetoff syndrome) came to our department as a depressed patient. She was hospitalized twice for depression and treated with antidepressants both times. Paroxetine (37.5 mg/day) treatment during the first hospitalization did not cause any side effects, but treatment with mirtazapine (15 mg/day) and venlafaxine (150 mg/day) during the second hospitalization caused clonus and disturbance of consciousness, and these adverse effects resulted in a prolonged period of hospitalization. Finally, the patient’s symptoms were controlled with quetiapine (75 mg/day). Conclusion Poor tolerability to antidepressants was observed, which may be related to thyroid hormone intolerance. Low doses of quetiapine may contribute to improvements in depression.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2574-173X
Relation: https://doaj.org/toc/2574-173X
DOI: 10.1002/npr2.12280
Access URL: https://doaj.org/article/56495d028e9b4e618937f6e3494edf3c
Accession Number: edsdoj.56495d028e9b4e618937f6e3494edf3c
Database: Directory of Open Access Journals
More Details
ISSN:2574173X
DOI:10.1002/npr2.12280
Published in:Neuropsychopharmacology Reports
Language:English